Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis

por Lax, Antonio, Soler, Fernando, Fernandez del Palacio, Maria Josefa, Pascual-Oliver, Silvia, Ballester, Miriam Ruiz, Fuster, Jose Javier, Pascual-Figal, Domingo, Asensio-Lopez, Maria del Carmen
Publicado 2023

Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status

por Asensio Lopez, Maria del Carmen, Lax, Antonio, Hernandez Vicente, Alvaro, Saura Guillen, Elena, Hernandez-Martinez, Antonio, Fernandez del Palacio, Maria Josefa, Bayes Genis, Andoni, Pascual Figal, Domingo A.
Publicado 2020